Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Di Renzo, Nicola
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Morabito F
,
Zamagni E
,
Conticello C
,
Pavone V
,
Palmieri S
,
Bringhen S
,
Galli M
,
Mangiacavalli S
,
Derudas D
,
Rossi E
, et al.
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Eur J Haematol. 2021.
PubMed
Google Scholar
B
Santoro A
,
Mazza R
,
Pulsoni A
,
Re A
,
Bonfichi M
,
Zilioli VRuggero
,
Salvi F
,
Merli F
,
Anastasia A
,
Luminari S
, et al.
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.
J Clin Oncol. 2016.
PubMed
Google Scholar
E
Di Renzo N
,
Melillo L
,
Porretto F
,
Dargenio M
,
Pavone V
,
Pastore D
,
Mazza P
,
Mannina D
,
Merenda A
,
Cascavilla N
, et al.
Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese".
Cancer Med. 2019.
PubMed
Google Scholar
F
Santoro A
,
Mazza R
,
Pulsoni A
,
Re A
,
Bonfichi M
,
Zilioli VRuggero
,
Zanni M
,
Merli F
,
Anastasia A
,
Luminari S
, et al.
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma.
Blood Adv. 2020;4(1):136-140.
PubMed
Google Scholar
I
Musso M
,
Messina G
,
Di Renzo N
,
Di Carlo P
,
Vitolo U
,
Scalone R
,
Marcacci G
,
Scalzulli PR
,
Moscato T
,
Matera R
, et al.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol. 2015.
PubMed
Google Scholar
R
Crump M
,
Kuruvilla J
,
Couban S
,
MacDonald DA
,
Kukreti V
,
C Kouroukis T
,
Rubinger M
,
Buckstein R
,
Imrie KR
,
Federico M
, et al.
Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12.
J Clin Oncol. 2014.
PubMed
Google Scholar
Gaudio F
,
Loseto G
,
Bozzoli V
,
Scalzulli PRosario
,
Mazzone AMaria
,
Tonialini L
,
Fesce V
,
Quintana G
,
De Santis G
,
Masciopinto P
, et al.
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.
Ann Hematol. 2023.
PubMed
Google Scholar
S
Kharfan-Dabaja MA
,
Labopin M
,
Ayala E
,
Bazarbachi A
,
Blaise D
,
Vydra J
,
Bramanti S
,
Itälä-Remes M
,
Schmid C
,
Busca A
, et al.
Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of th
. Hemasphere. 2023;7(7):e920.
PubMed
Google Scholar